Insider Trading & Ownership - Turka Laurence A.

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Turka Laurence A.
Common stock purchase or sale:
Transaction
Date		Reported
DateTime		CompanySymbolInsider
Relationship		Shares
Traded		Average
Price		Total
Amount		Shares
Owned		Filing
2023-01-31
Sale		2023-01-31
9:50 pm		Rubius Therapeutics Inc.RUBYTurka Laurence A.
Chief Scientific Officer		2,593$0.24$62259,140
(Direct)		View
2022-02-01
Sale		2022-02-01
9:18 pm		Rubius Therapeutics Inc.RUBYTurka Laurence A.
Chief Scientific Officer		2,517$6.573$16,544205,483
(Direct)		View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date		Reported
DateTime		Exercisable
Expiration		CompanySymnbolInsider
Relationship		Shares
Traded		Conversion
Price		Shares
Owned		Filing
2023-01-29
Exercise		2023-01-31
9:50 pm		N/A
N/A		Rubius Therapeutics Inc.RUBYTurka Laurence A.
Chief Scientific Officer		16,063$059,140
(Direct)		View
2022-01-29
Exercise		2022-02-01
9:18 pm		N/A
N/A		Rubius Therapeutics Inc.RUBYTurka Laurence A.
Chief Scientific Officer		7,438$0205,483
(Direct)		View
2022-01-31
Option Award		2022-02-01
9:18 pm		N/A
2032-01-30		Rubius Therapeutics Inc.RUBYTurka Laurence A.
Chief Scientific Officer		178,250$0205,483
(Direct)		View
2021-01-29
Option Award		2021-02-02
8:27 pm		N/A
2031-01-28		Rubius Therapeutics Inc.RUBYTurka Laurence A.
Chief Scientific Officer		161,000$0161,000
(Direct)		View
2020-01-31
Option Award		2020-02-03
9:48 pm		N/A
2030-01-30		Rubius Therapeutics Inc.RUBYTurka Laurence A.
Chief Scientific Officer		350,000$0350,000
(Direct)		View